Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ETEPLIRSEN
- A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of Casimersen, Eteplirsen and Golodirsen in Subjects With Duchenne Muscular Dystrophy Carrying Eligible DMD Duplications
- A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Duchenne Muscular Dystrophy (DMD) Patients (MIS51ON)
- A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Patients With Duchenne Muscular Dystrophy
- Study of Eteplirsen in Young Patients With DMD Amenable to Exon 51 Skipping
- Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy
- Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
- Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy
- Study of Eteplirsen in DMD Patients
- Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
- Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients
- Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients
Clinical trials list
click for details